AxoGen (NASDAQ:AXGN) Rating Lowered to Hold at StockNews.com

StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday. A number of other research analysts have also weighed in on AXGN. Cantor Fitzgerald reissued an overweight rating and set a $12.00 price target on shares of AxoGen in […]

Related Keywords

Switzerland ,Swiss ,Peterj Mariani , ,Cantor Fitzgerald ,Raymond James Financial Services Advisors Inc ,Metlife Investment Management ,Axogen Company Profile ,Jpmorgan Chase Co ,Vanguard Group Inc ,Axogen Inc ,Canaccord Genuity Group ,Swiss National Bank ,Free Report ,Genuity Group ,Moderate Buy ,National Bank ,James Financial Services Advisors ,Life Investment Management ,Vanguard Group ,Get Free Report ,Avance Nerve Graft ,Axoguard Nerve Connector ,Axoguard Nerve Protector ,Axogen Daily ,Axogen ,Nasdaq Axgn ,Axgn ,Medical ,Downgrade ,Stocknews Com ,